Related Experiment Video
Updated: May 12, 2026
05:45
Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
Report From the International Conference on Incontinentia Pigmenti: Translating Discovery to Therapy
Reid Wilson1, Nicole Somani2, Nancy Arias3
1Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.
American Journal of Medical Genetics. Part A
|May 11, 2026
Summary
Incontinentia pigmenti (IP) is a rare genetic disorder. This report details recommendations from an international conference to improve understanding and management of IP's severe CNS and ophthalmic complications.
Area of Science:
- Genetics
- Dermatology
- Neurology
- Ophthalmology
Background:
- Incontinentia pigmenti (IP) is a rare X-linked dominant disorder.
- Characterized by a perinatal rash and abnormalities of the CNS, eyes, hair, nails, and teeth.
- Severe CNS and ophthalmic manifestations can cause neurologic impairment and vision loss.
Purpose of the Study:
- To address limited understanding of IP physiology.
- To establish guidelines for screening, staging, and management of IP complications.
- To discuss and recommend next steps for therapeutic interventions.
Main Methods:
- A multidisciplinary, international conference on IP was convened.
- Discussions focused on current knowledge and challenges in IP management.
- Recommendations were formulated based on expert consensus.
Main Results:
- Guidance for screening of ophthalmic complications was established.
- Next steps for pursuing therapeutic interventions were identified.
- The report summarizes conference discussions and recommendations.
Conclusions:
- Improved understanding and standardized management are crucial for IP patients.
- Further research is needed to develop effective therapeutic interventions.
- International collaboration is key to advancing IP care.
Keywords:
dermatologyectodermal dysplasiageneticsincontinentia pigmentineovascularizationophthalmologyretinaMore Related Videos
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...